Primecap Management
MBII

Primecap Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Primecap Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,458,400
Closed -$1.69M – 345
2022
Q2 		$1.69M Sell
1,458,400
-60,700
-4% -$63.5K ﹤0.01% 308
2022
Q1 		$1.64M Sell
1,519,100
-64,700
-4% -$48.9K ﹤0.01% 316
2021
Q4 		$1.14M Sell
1,583,800
-116,200
-7% -$94K ﹤0.01% 330
2021
Q3 		$1.53M Sell
1,700,000
-224,000
-12% -$270K ﹤0.01% 322
2021
Q2 		$3.19M Sell
1,924,000
-12,800
-0.7% -$21.4K ﹤0.01% 301
2021
Q1 		$4.05M Sell
1,936,800
-46,400
-2% -$96.4K ﹤0.01% 293
2020
Q4 		$2.48M Sell
1,983,200
-52,100
-3% -$62.2K ﹤0.01% 300
2020
Q3 		$2.48M Sell
2,035,300
-155,000
-7% -$188K ﹤0.01% 277
2020
Q2 		$2.56M Sell
2,190,300
-60,300
-3% -$55.8K ﹤0.01% 267
2020
Q1 		$1.84M Sell
2,250,600
-70,000
-3% -$74.2K ﹤0.01% 262
2019
Q4 		$2.34M Sell
2,320,600
-30,000
-1% -$36.4K ﹤0.01% 271
2019
Q3 		$3.31M Sell
2,350,600
-130,110
-5% -$184K ﹤0.01% 256
2019
Q2 		$3.72M Sell
2,480,710
-138,890
-5% -$215K ﹤0.01% 265
2019
Q1 		$4.01M Sell
2,619,600
-6,000
-0.2% -$9.15K ﹤0.01% 260
2018
Q4 		$3.86M Hold
2,625,600
– – ﹤0.01% 255
2018
Q3 		$4.8M Hold
2,625,600
– – ﹤0.01% 264
2018
Q2 		$4.83M Hold
2,625,600
– – ﹤0.01% 255
2018
Q1 		$5.25M Hold
2,625,600
– – ﹤0.01% 254
2017
Q4 		$2.89M Sell
2,625,600
-30,000
-1% -$30.7K ﹤0.01% 261
2017
Q3 		$3.05M Sell
2,655,600
-47,270
-2% -$53.8K ﹤0.01% 256
2017
Q2 		$3.49M Sell
2,702,870
-17,045
-0.6% -$24.2K ﹤0.01% 259
2017
Q1 		$5.3M Sell
2,719,915
-123,285
-4% -$261K ﹤0.01% 252
2016
Q4 		$6.08M Sell
2,843,200
-77,800
-3% -$162K 0.01% 245
2016
Q3 		$5.02M Sell
2,921,000
-137,700
-5% -$167K 0.01% 246
2016
Q2 		$2.51M Sell
3,058,700
-157,400
-5% -$122K ﹤0.01% 254
2016
Q1 		$2.89M Sell
3,216,100
-24,100
-0.7% -$24.3K ﹤0.01% 250
2015
Q4 		$3.56M Sell
3,240,200
-1,900
-0.1% -$4.07K ﹤0.01% 248
2015
Q3 		$6.84M Hold
3,242,100
– – 0.01% 232
2015
Q2 		$6.42M Hold
3,242,100
– – 0.01% 227
2015
Q1 		$12.5M Hold
3,242,100
– – 0.01% 214
2014
Q4 		$11.7M Hold
3,242,100
– – 0.01% 216
2014
Q3 		$8.62M Buy
3,242,100
+200,081
+7% +$1.34M 0.01% 218
2014
Q2 		$35.3M Buy
3,042,019
+1,540,036
+103% +$17.5M 0.04% 172
2014
Q1 		$21M Buy
1,501,983
+1,102,883
+276% +$17.3M 0.02% 188
2013
Q4 		$7.1M Sell
399,100
-35,900
-8% -$583K 0.01% 223
2013
Q3 		$7.33M Buy
+435,000
New +$6.11M 0.01% 218

Primecap Management's MBII Position: Q3 2022 in Review

Primecap Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 1,458,400 shares — an estimated $1.69M sold.

Primecap Management first reported a position in MBII in Q3 2013 and held it in 36 quarters. The position peaked at $35.3M in Q2 2014. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Primecap Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Primecap Management sold 1,458,400 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1.69M.
  • Primecap Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 36 quarters.
  • Primecap Management's Marrone Bio Innovations, Inc. position peaked at $35.3M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Primecap Management's 13F filing for Q3 2022, filed 14 Nov 2022.